What Is Precision Medicine? A Simple Guide to Personalized Treatment

For most of medical history, treatment worked like this: You get sick, a doctor figures out what’s wrong and you get the same medication that works for most people with that condition. 

It’s a reasonable system. It’s also a little like buying pants in one size and hoping for the best. 

Precision medicine, also called personalized medicine, is the alternative. The goal is to help providers choose treatments more likely to work for the right patient at the right time. Pharmacology plays a major role in making that possible. 

What Is Precision Medicine? 

Precision medicine is an approach to healthcare that tailors treatment to the individual rather than the general population. Instead of asking, “what works for most people with this condition?”, it asks: “What will work best for this specific person, given their unique biology?” 

That might mean: 

• Choosing a cancer drug based on the genetic makeup of a patient’s tumor 
• Adjusting a medication dose based on how someone’s liver processes it 
• Identifying that a common treatment could be harmful for someone with a particular genetic variation 

Precision medicine began in oncology, but its success and popularity have extended its reach into everyday clinical care. The goal remains the same: Get the right treatment to the right person at the right time. 

How Pharmacology Supports Personalized Medicine 

Pharmacology is the study of how drugs interact with the body. It’s what makes precision medicine … well, precise. Knowing that a drug exists is one thing, but knowing how a specific patient’s body will absorb, process and respond to it is another. 

That’s where pharmacogenomics enters the chat. Rather than a one-size-fits-all approach to prescribing, pharmacogenomics examines how a person’s genes influence their response to medication — and those differences can be significant. 

Genetic variation between people can affect: 

• Whether a drug works 
• How well it works 
• Whether it causes side effects 

One way researchers and clinicians track these differences is through biomarkers. Think of them like medical clues: They don’t tell the whole story, but they help clinicians understand why one patient responds beautifully to a medication while another barely responds at all. 

In oncology, for example, biomarkers like BCR-ABL (leukemia), BRAF (melanoma), ALK and EGFR (lung cancer) have helped match patients with therapies more likely to work for their specific disease. It’s a far cry from the trial-and-error approach that used to be standard. 

What Does Precision Medicine Look Like in Practice? 

Precision medicine and pharmacogenomics are already showing up in real clinical settings: 

Precision Medicine in Oncology 

Tumor genetic testing is now standard for many cancers. Doctors use it to identify which drugs are most likely to work against a specific tumor’s mutations, rather than defaulting to a broad chemotherapy protocol. 

Personalized Medicine in Psychiatry 

Consider three people taking the same antidepressant at the same dose. One might feel better within weeks, while another feels nothing — and a third has a reaction that sends them back to their doctor. That’s not random, and a lot of it comes down to genetics. 

Variations in the CYP2D6 gene affect how the body metabolizes many common antidepressants, and testing for those variants before prescribing can mean the difference between a drug working as expected and causing serious side effects. 

Personalized Medicine in Cardiology 

Genetic testing can flag patients who are poor metabolizers of common blood thinners like warfarin, helping doctors adjust doses before a problem occurs rather than after. 

The common thread: Genetic information helps clinicians make smarter, safer and more individualized treatment decisions, which is exactly what precision medicine promises. 

Is Precision Medicine Available to Everyone? 

Precision medicine is promising, but it isn’t equally available to all patients. A few key barriers are slowing down wider adoption: 

Cost 

Genetic testing, biomarker analysis and targeted therapies can be expensive. The research and development behind precision treatments alone can run into the billions, and those costs often get passed downstream to patients and healthcare systems. 

Insurance Coverage Gaps 

Many patients can’t access precision medicine because most public and private insurers don’t cover genetic or genomic services unless specific clinical criteria are met. That leaves many patients without access, even when the science exists to help them. 

Provider Education 

Precision medicine tools are only useful if providers know to use them. Many clinicians aren’t yet familiar with when or how to order genetic testing, which means patients who could benefit often never get the option. 

The good news is that researchers, policymakers and healthcare organizations are actively working to close these gaps, and progress is being made on both expanding insurance coverage and reducing sequencing costs. 

Advance Your Career in Pharmacology and Precision Medicine 

Precision medicine is a growing field, and that growth means demand for people who understand both the science and what it takes to apply it in real clinical settings. 

UF’s online master’s degree in medical physiology and pharmacology is a natural next step if this is the direction you want to take your career. It’s fully online and built for working adults: people with jobs, families and schedules that don’t have room for a traditional on-campus program. 

Visit the Programs page to learn more about UF’s master’s degree in medical physiology and pharmacology and other fully online options.